Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
Department of Ophthalmology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, No. 71, Hexi Road, Nanjing, 210019, Jiangsu Province, China.
BMC Ophthalmol. 2020 Sep 29;20(1):387. doi: 10.1186/s12886-020-01655-y.
To compare the efficacy and safety of focused ultrasound cycloplasty (UCP) and transscleral cyclophotocoagulation (TSCP) in the treatment of refractory glaucoma in a Chinese population.
We retrospectively compared twenty-eight eligible patients with refractory glaucoma, who were divided into the UCP group and TSCP group. Patients in these two groups underwent a corresponding procedure from June 2018 to February 2019. The intraocular pressure (IOP), visual acuity, the number of anti-glaucoma agents used and complications were reviewed and compared between groups. Proper statistical methods were selected according to comparison models under IBM SPSS 25 software.
After the 12-months follow-up, postoperative IOP and number of anti-glaucoma agents used in the two groups were both reduced than the baseline level, and the differences were statistically significant (P < 0.05). There were no significant differences in IOP, number of anti-glaucoma agents and the best-corrected visual acuity between the two groups at each follow-up time point (P>0.05). In terms of complications, the pain at 1 day after surgery in the UCP group was significantly milder than that in the TSCP group (P < 0.05). And there were no significant differences in other complications between the two groups (P > 0.05).
Both UCP and TSCP are safe and effective methods for the treatment of refractory glaucoma. Nevertheless, pain is less severe after UCP.
比较聚焦超声睫状体成形术(UCP)和经巩膜睫状体光凝术(TSCP)在中国人难治性青光眼治疗中的疗效和安全性。
我们回顾性比较了 28 例符合条件的难治性青光眼患者,将其分为 UCP 组和 TSCP 组。两组患者分别于 2018 年 6 月至 2019 年 2 月接受相应治疗。比较两组患者的眼压(IOP)、视力、抗青光眼药物使用数量和并发症。采用 IBM SPSS 25 软件,根据比较模型选择合适的统计方法。
12 个月随访后,两组患者术后 IOP 和抗青光眼药物使用数量均低于基线水平,差异有统计学意义(P<0.05)。两组患者在每个随访时间点的 IOP、抗青光眼药物使用数量和最佳矫正视力均无显著差异(P>0.05)。在并发症方面,UCP 组术后 1 天疼痛明显轻于 TSCP 组(P<0.05)。两组其他并发症无显著差异(P>0.05)。
UCP 和 TSCP 均是治疗难治性青光眼的安全有效的方法,但 UCP 术后疼痛较轻。